EMS 0.00% 3.2¢ eastland medical systems ltd

*** ems the next uni (unitract)

  1. 346 Posts.

    Issuer Name: EASTLAND MEDICAL SYSTEMS LTD
    Description: ORDINARY FULLY PAID

    Security Last +/- Bid Ask Volume Value Basis R Status High Low Ex
    EMS 30 1.5 29.5 30 2173760 654031 31.5 27.5 ASX
    High Low Volume Value
    Week Rolling 34 19.5 13624299 4129287
    Month Rolling 34 18 14936719 4391172
    Year Rolling 34 5.7 33051038 8576369
    Prev. Year 28 5.7 13293531 2278370
    First Listed Date : 24-Jan-2002 Paid Up Value : 0.00
    Last Listed Date : Par Value : 0.00
    Suspension Date : Asset Backing : 1.00
    Currency : AUD Price / NTA : 30.00
    Shares On Issue : 23676121 EPS : -1.18
    Market Cap ($) : 6747694 PE Ratio : -25.42
    Sub-Industry : Health Care Equipment & Services - 3510 Yearly Dividend : 0
    Div Yield (%) : 0.00

    EASTLAND MEDICAL SYSTEMS LTD 2003-04-15 ASX-SIGNAL-G

    HOMEX - Perth

    +++++++++++++++++++++++++
    Eastland Medical Systems Ltd is pleased to announce that it has now
    completed the development of their patented "Reversyringe" Device.

    "Reversyringe" is the only true automatic retract syringe in the
    world that retracts and self destructs during operation of any
    procedure without the need for healthcare workers to activate the
    retraction. "Reversyringe" achieves its automatic retraction and self
    destruction without the need for the use of springs or activation by
    the user.

    The use of springs in retraction of needles in retractable syringes
    has been a World wide problem in the mass production by automated
    assembly and is still a major problem adding cost and downtime due to
    the tangling of springs.

    "Reversyinge" has granted patents and its targeted market is the
    pre-filled syringe market incorporating mass immunisation programs
    and the specialist self administration markets.

    "Reversyringe", like all of Eastland safe products, can be rendered
    safe at any time during a procedure, an essential function of a truly
    safe device. This product has been developed to compete with other
    more complicated devices within the retractable syringe market.

    The development of the P A P needle technology, developed at the
    Portland facility, now provides Eastland's full range of injectable
    devices with considerable advantages over its competitors, not only
    in design and function but also cost. The cost of needles will now be
    reduced by half when Eastland introduce the manufacturing of its own
    needles at Portland.

    The patents owned by Eastland Medical Systems - including its unique
    Clip-On syringe converter for the prevention of needlestick injuries
    - have been acquired and developed to respond to the international
    demands of the health industry.

    Marina Valmadre Don O'Sullivan, CEO AND MANAGING
    Oak Ridge Communication Group DIRECTOR
    (08) 9481-4566 or 0408 98 28 18 Eastland Medical Systems Ltd
    or (08) 9481-1844
    Email; [email protected]
    Website; www.eastlandmedical.com

 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.